Stephen Uden
Vermogen: 2 M $ op 31-08-2026
Vermogen: 2 M $ op 31-08-2026
Dr. Stephen Uden, MD, is a President, Chief Executive Officer & Director at Rallybio Corp.
and a President, Chief Executive Officer & Director at Rallybio LLC.
He is on the Board of Directors at Rallybio Corp.
and Rallybio LLC.
Dr. Uden was previously employed as a Senior Vice President-Research by Alexion Pharmaceuticals, Inc. and a Head-Research & Development by Neurogen Corp.
He received his undergraduate degree from the University of London.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RALLYBIO CORPORATION 1,73% | 19-12-2025 | 91.920 ( 1,73% ) | 2 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RALLYBIO CORPORATION | Oprichter | 01-01-2018 |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Oprichter | 01-01-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-10-2017 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Hoofd Techniek/Wetenschap/O&O | 14-09-2007 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Commercial Services |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau